China’s single-shot Covid-19 vaccine safe for children at lower dosage, tests find
Published
Sep 24 2021 at 6:00 AM GMT
Key
Points
Points
- CanSino Biologics’ single-dose Covid-19 vaccine, given at a lower dosage than that for adults, is safe and triggers an immune response in children aged six-17, results from a small trial showed.
- Researchers decided to lower the dosage after a few participants developed fever and headaches graded at level 2 severity – the second-lowest of four levels.
- In children, the lower dose triggered higher antibody levels than the dosage approved for use in adults in China, according to the peer-reviewed….
Trending
Stats
- Published Sep 24, 2021 6:00 AM GMT